Journal of Neuro-Oncology

, Volume 64, Issue 3, pp 249–253

Brain Metastases in Patients with Cancer of Unknown Primary

  • Susanne Bartelt
  • Johannes Lutterbach

DOI: 10.1023/A:1025621819250

Cite this article as:
Bartelt, S. & Lutterbach, J. J Neurooncol (2003) 64: 249. doi:10.1023/A:1025621819250


Between January 1985 and December 2000, 916 patients with brain metastases were treated with whole brain radiation therapy (WBRT) at the Department of Radiotherapy, University Hospital Freiburg. In 47 patients, a primary tumor could not be identified (cancer of unknown primary (CUP)). Sixteen patients had a solitary brain metastasis, 31 patients presented with multiple brain metastases. Surgical resection was performed in 15 patients, biopsy alone in 12 patients. WBRT was applied with daily fractions of 2 or 3Gy to a total dose of 50 or 30Gy, respectively. According to the recursive partitioning analysis (RPA) classes of the Radiation Therapy Oncology Group for patients with brain metastases none of the patients met the criteria for Class I, 23 for Class II, and 24 for Class III.

The median overall survival (OS) for all patients with brain metastases (n = 916) was 3.4 and 4.8 months for patients with CUP (p = 0.45). In patients with CUP (n = 47) the median OS for patients with a single brain metastasis was 7.3 versus 3.9 months for patients with multiple brain metastases (p = 0.05). Median OS for patients with a Karnofsky performance status (KPS) ≥70 was 6.3 months versus 3.2 months for KPS <70 (p = 0.01).

At multivariate analysis performance status and resection status could be identified as independent prognostic factors for the OS.

brain metastasiscancer of unknown primaryprognostic factorssurvivalwhole brain radiation therapy

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • Susanne Bartelt
    • 1
  • Johannes Lutterbach
    • 1
  1. 1.Department of Radiation OncologyUniversity of FreiburgFreiburg i. Br.Germany